Conference Info:Date: June 26-27, 2013
Location: The Metropolitan Club, New York City
Audience: Institutional investors, high net worth individual investors, family offices, business development executives throughout the US and Europe building and financing high growth medical technology, health care and life science companies.
View the Schedule!
View the Agenda!
Securing Funding After the JOBS Act: Promises and Pitfalls
Accessing Capital and Reaching Liquidity: The Dramatic Catalyst of the JOBS Act
Thursday, June 27th: 8:20AM- 9:10AM
The JOBS Act has created many new channels for companies exploring entrance into the public markets. Of particular interest are changes to Regulation D, Regulation A, which could become a major new financing tool for smaller companies to enter the public markets via a more friendly on-ramp.
Experts maintain that sustained growth in the industry is directly tied to a healthy and ever-expanding number of life sciences companies entering public markets. However, a funding gap for companies in mid-level rounds has threatened to stymie industry growth, and this gap may be expanding, in which earlier-stage companies may be mired in purgatory.
The JOBS Act — with the expansion of the investor pool for private companies, new accreditation levels, and more efficient compliance guidelines — may infuse more later-round capital and in turn facilitate more entrance to public markets. This expert panel will discuss the logistics and opportunity of the JOBS Act, exploring:
- How has the JOBS Act changed the traditional definition of Reg A and Reg D?
- Which companies are best-suited to undertake non-traditional late-round financing methods?
- How can companies maintain liquidity, float, sharevalue, and avoid toxic death spirals?
- What must companies do before the fundraising stage to secure valuation?
- What prior case studies exist for new fundraising strategies?
- How do potentially new strategies appeal to early institutional investors?
- What is the investor demographic that participates in Reg A & Reg D?
- What is the long-term strategy/exit strategy of companies engaging in a new IPO on-ramp?
- How does the expanding of the number of shareholders within a private company affect growth strategy?
- How does the JOBS Act facilitate liquidity?
Ryan Starkes, CPA, Practice Leader and Assurance Partner, BDO, Ryan has over 18 years of experience and serves as BDO’s LifeSciences Practice Leader with responsibility for managing all aspects of the firm-wide industry group. Ryan has worked with start-up through well-established companies, both public and privately held, throughout the New Jersey, New York, and Long Island business communities in a wide variety of transactions including M&A as well as private and public offerings.
Paul Getty, Managing Director, Satwik Ventures, Based in Silicon Valley, Paul Getty is a Managing Director of Satwik Ventures, an advisory and investment firm focusing on late stage companies who are utilizing JOBs Act legislation to raise growth capital. The Satwik Ventures team has invested in 45 firms that have resulted in over $1 Billion in exits via IPOs and acquisitions. Paul also co-founded First Guardian Group (FGG) in 2003, a real estate investment and management firm focusing on the development, selection, and management of over $800 million of commercial real estate offerings. His prior operating experience spans over 25 years as a serial entrepreneur and executive officer in firms that resulted in investor returns of over $700 million through multiple successful IPOs and M&As. Paul is also principal author of Regulation A+: A New Way to Raise Funds for Emerging Growth Companies, to be published later this year by Apress Publishing. Paul holds an MBA in Finance from the University of Michigan, graduating with honors, and a Bachelor’s Degree in Chemistry. He also completed post graduate studies in physics and electrical engineering. He is a licensed real estate broker and is currently completing a FINRA Series
Granville A Ungerleider, Managing Member, NSIP LLC, Managing Member, President, Ellington Healthcare Asset Management LLC, is an accomplished Senior Executive, Banker, and Venture Capitalist with a distinguished record of success over his thirty plus years of healthcare strategic advisory and investment banking services. He has initiated, led and implemented a broad array of initiatives with an emphasis on financial restructurings, mergers & acquisitions, divestitures, private equity investments, and public offerings of debt & equity including taxable and tax-exempt financings across a diverse set of industry sectors and geographic boundaries. Currently, Mr. Ungerleider is a Managing Member of NSIP LLC the General Partner of Ellington Healthcare Partners L.L.P., an early stage venture capital investment fund that will target companies with unique therapies using adult stem cells which typically are bone-marrow derived, nanotechnology devices, or molecular targeted, oncologic pharmaceuticals that clearly demonstrate potential breakthroughs in the treatment of disease or possess competitive advantages over currently-marketed products. Mr. Ungerleider has served as a Member of the Finance Committees for members of Congress. He was an arbitrator for the New York Stock Exchange. Mr. Ungerleider received a B.S. in Finance from New York University, an M.B.A. from Southern Illinois University and an MS in Accounting from Temple University. He holds the series 24, 7, 53, 63, 79 and 99 licenses.
DJ Paul, CSO, GATE Technologies. As Chief Strategy Officer with GATE Impact, DJ Paul develops solutions to facilitate and expand private and alternative asset transactions, including crowdfunding and 506/Regulation D securities. DJ is nationally known for his expertise in regulatory compliance and electronic infrastructures and is regarded as one of the pioneers of the crowdfund investing movement. His desire to find solutions that work for investors, issuers and federal policymakers during and immediately after passage of the JOBS Act led him to coordinate the first post-JOBS Act meeting between the Securities Exchange Commission and crowdfunding stakeholders. This milestone meeting catalyzed and launched an ongoing collaboration that continues to this day between the SEC, federal elected officials, Wall Street and Main Street business leaders and crowdfunding advocates who are working together to shape regulatory oversight and implementation of the new industry. DJ is co-founder and executive board member of two national crowdfunding organizations: Crowdfunding Intermediary Regulatory Advocates (CfIRA) and Crowdfunding Professional Association (CfPA). He is frequently asked to publish and speak on themes related to regulatory compliance and sustainable policies and practices related to crowdfund securities in the US and abroad. Prior to joining GATE, DJ co-founded Crowdfunder, a Los-Angeles based crowdfunding intermediary platform where he served as Chief Strategy Officer. His financial services career includes sovereign and high-yield bond portfolio management positions at Banque Paribas (London) and CenTrust Bank (Miami), as well as mortgage-backed securities sales with Cowan & Co on Wall Street. Prior to entering the crowdfunding space, DJ spent 15 years as an award-winning film and television producer. DJ earned his BA in Philosophy from Brown University. He is a certified crisis counselor and Wilderness First Responder – valuable skills for the concrete jungles he calls home: Los Angeles and New York City.
Additional participants to be named in the coming days.